Adagio pledges to press forward with COVID drug as CEO to resign
Dive Brief:
Adagio Therapeutics CEO Tillman Gerngross has agreed "in principle" to resign as head of the COVID-19 drug developer amid confusion over whether its mo...
Mastering ADC Bioconjugation: From DAR Control to Efficient Free Payload Removal
Continue readingAdvertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.